Back to results
US 2022/0033502 A1Published application
METHODS FOR UPREGULATING IMMUNE RESPONSES USING COMBINATIONS OF ANTI-RGMb AND ANTI-PD-1 AGENTS
AssigneeDana-Farber Cancer Institute, Inc.
InventorsGordon J. Freeman, Yanping Xiao
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents.
Claims10
1-29. (canceled)
A kit for treating a subject having a condition that would benefit from upregulation of an immune response comprising at least one agent that selectively inhibits or blocks the expression or activity of both RGMb and PD-1.
(canceled)
Dependencies are inferred from the claim text.